98%
921
2 minutes
20
Objective: The aim of this study was to evaluate the clinical outcome in locally advanced cervical cancer (LACC) after image-guided adaptive brachytherapy (IGABT) with combined intracavitary and interstitial (IC/IS) techniques using the hybrid Venezia applicator (Elekta AB, Sweden).
Methods: LACC patients (UICC Stage IIB - IVB) treated with radiochemotherapy followed by IGABT with the hybrid IC/IS Venezia applicator at a single institution were retrospectively analyzed. Treatment comprised EBRT of the pelvis with 45 Gy and concomitant weekly cisplatin chemotherapy (40 mg/m) followed by MRI-based IGABT. Dosimetry, oncological outcome and toxicity were investigated.
Results: Forty-six patients underwent a total of 184 fractions of IGABT between 2017 and 2020. Median follow-up was 24 months. Combined IC/IS techniques were used in 40 patients (87%). The median HRCTV volume was 31.2 cm and the median HRCTV D was 92.3 Gy (EQD2). The median D was 74.8 Gy for bladder, 57.9 Gy for rectum, 60.0 Gy for sigmoid and 52.2 Gy for bowel (EQD2). The 3-yr actuarial rates were 97.6% for local control, 97.6% for pelvic control, 59.9% for distant metastasis-free survival and 81.6% for overall survival. The crude rate for G2 and G3 late toxicity was 21.7% and 4.3%.
Conclusions: IGABT with the hybrid Venezia applicator and a pronounced use of a combined IC/IS technique achieved high target doses, while maintaining low doses to organs at risk, leading to excellent local control and overall survival rates with acceptable toxicity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ygyno.2022.06.019 | DOI Listing |
Brachytherapy
August 2025
Department of Radiation Oncology, Osaka International Cancer Institute, Chuo-ku, Osaka, Japan.
Purpose: This study aimed to evaluate the inter-applicator differences in source positions of the Geneva and Venezia applicators by using X-ray fluoroscopy to perform direct measurements of iridium-192 (Ir) source positions.
Materials And Methods: Offset measurements of two to six sets of Geneva tandem and ovoid applicators and Venezia tandem applicators were performed. Each applicator was irradiated with Ir at the most distal position and X-ray fluoroscopy images were acquired.
Pract Radiat Oncol
June 2025
Liv Hospital Ulus, Department of Radiation Oncology, Istanbul, Turkey; Faculty of Medicine, Department of Radiation Oncology, Istinye University, Istanbul, Turkey.
Purpose: This study evaluated the clinical feasibility of hybrid brachytherapy and the benefits of computed tomography (CT) guidance for optimizing applicator position and needle placement via Utrecht or Venezia applicators in the curative treatment of vaginal cuff recurrence.
Methods And Materials: Sixteen previously operated patients with gynecological cancer treated with hybrid brachytherapy for vaginal cuff recurrence from 2018 to 2022 were included. The applicators were selected according to vaginal diameter and tumor location.
Ecancermedicalscience
April 2025
Department of Oncology, Atomic Energy Cancer Hospital NORI, Islamabad 44000, Pakistan.
Objective: To evaluate the efficacy and acute toxicity of hybrid brachytherapy using Venezia applicators in patients with locally advanced squamous cell carcinoma of the cervix.
Methods: This prospective study involved 41 patients treated with external beam radiotherapy (EBRT) followed by brachytherapy. Patients received EBRT doses of 45-50.
Phys Med Biol
June 2025
Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
In brachytherapy for gynecological cancers using intracavitary applicators, implant reconstruction is commonly performed using applicator libraries. These libraries contain applicator geometry models as well as dwell position (DP) models defined in respect to the applicator geometry. In this study, we investigate whether an afterloader integrated electromagnetic tracking (EMT) system can be utilized for DP model definition and quality assurance in such applicators.
View Article and Find Full Text PDFBrachytherapy
August 2025
Princess Margaret Cancer Center, Toronto, Ontario, Canada; University of Toronto, Department Radiation Oncology, Toronto, Ontario, Canada; University of Toronto, Department Medical Biophysics, Toronto, Ontario, Canada; University of Toronto, Institute of Biomedical Engineering, Toronto, Ontario, Can
Purpose: We propose a new method for commissioning lunar ovoid applicators in high dose rate gynecology brachytherapy based on 2D optical scintillating imaging of the applicators.
Methods: Treatment plans were generated for 22 mm and 26 mm diameter Venezia applicators, using four to eight dwell positions in each ovoid. Images of the applicator dwell positions were acquired using a pinhole apparatus combined with scintillating material and optical camera.